Skip to main content

Introducing Rubraca


6:30 pm - 9:00 pm


LB Steak
334 Santana Row Suite 1000, San Jose, CA
Loading Map....

You are invited to attend a Presentation and Dinner – Introducing Rubraca

Presented by: John Chan MD

Rubraca™ is indicated as monotherapy for the treatment of patients with deleterious BRCA mutation (germline and/or somatic) associated advanced ovarian cancer who have been treated with two or more chemotherapies. Select patients for therapy based on an FDA-approved companion diagnostic for Rubraca.


Download a copy of this Event